The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
SAT02 - Breakfast Activity/Non-CE Satellite Symposium: Intervening with Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Resource for Advanced Practice Professionals - Incyte Corporation